Pacific Edge Limited (PEB.AX)
AUD 0.11
(4.76%)
AUD 0.11
(4.76%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 26.06 Million NZD | 32.86% |
| 2023 | 19.61 Million NZD | 71.39% |
| 2022 | 11.44 Million NZD | 431.83% |
| 2021 | 2.15 Million NZD | -50.76% |
| 2020 | 4.37 Million NZD | 14.49% |
| 2019 | 3.81 Million NZD | 12.26% |
| 2018 | 3.4 Million NZD | -57.83% |
| 2017 | 8.06 Million NZD | 62.03% |
| 2016 | 4.97 Million NZD | 161.87% |
| 2015 | 1.9 Million NZD | 263.29% |
| 2014 | 523 Thousand NZD | 187.36% |
| 2013 | 182 Thousand NZD | -8.08% |
| 2012 | 198 Thousand NZD | 39500.0% |
| 2011 | 500.00 NZD | 0.0% |
| 2010 | - NZD | -100.0% |
| 2009 | 220 Thousand NZD | 168.29% |
| 2008 | 82 Thousand NZD | 0.0% |
| 2007 | - NZD | 0.0% |
| 2006 | - NZD | -100.0% |
| 2005 | 50 Thousand NZD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q4 | 5.63 Million NZD | 0.0% |
| 2024 Q1 | 6.97 Million NZD | 20.66% |
| 2024 Q2 | 6.97 Million NZD | 0.0% |
| 2024 Q3 | 5.63 Million NZD | -19.2% |
| 2024 FY | 26.06 Million NZD | 32.86% |
| 2023 Q4 | 5.78 Million NZD | 0.0% |
| 2023 FY | 19.61 Million NZD | 71.39% |
| 2023 Q3 | 5.78 Million NZD | 22.15% |
| 2023 Q2 | 4.73 Million NZD | 0.0% |
| 2023 Q1 | 4.73 Million NZD | 35.04% |
| 2022 Q2 | 3.06 Million NZD | 0.0% |
| 2022 Q3 | 3.5 Million NZD | 14.47% |
| 2022 Q4 | 3.5 Million NZD | 0.0% |
| 2022 FY | 11.44 Million NZD | 431.83% |
| 2022 Q1 | 3.06 Million NZD | 13.55% |
| 2021 Q2 | 1.79 Million NZD | 0.0% |
| 2021 Q1 | 1.79 Million NZD | 50.97% |
| 2021 Q4 | 2.69 Million NZD | 0.0% |
| 2021 FY | 2.15 Million NZD | -50.76% |
| 2021 Q3 | 2.69 Million NZD | 50.63% |
| 2020 Q3 | 1.18 Million NZD | -7.6% |
| 2020 FY | 4.37 Million NZD | 14.49% |
| 2020 Q4 | 1.18 Million NZD | 0.0% |
| 2020 Q2 | 1.28 Million NZD | 0.0% |
| 2020 Q1 | 1.28 Million NZD | 10.08% |
| 2019 Q3 | 1.16 Million NZD | -5.78% |
| 2019 FY | 3.81 Million NZD | 12.26% |
| 2019 Q1 | 1.23 Million NZD | -7.61% |
| 2019 Q4 | 1.16 Million NZD | 0.0% |
| 2019 Q2 | 1.23 Million NZD | 0.0% |
| 2018 Q1 | 981.5 Thousand NZD | 140.56% |
| 2018 FY | 3.4 Million NZD | -57.83% |
| 2018 Q4 | 1.33 Million NZD | 0.0% |
| 2018 Q2 | 981.5 Thousand NZD | 0.0% |
| 2018 Q3 | 1.33 Million NZD | 36.47% |
| 2017 Q3 | 408 Thousand NZD | -76.67% |
| 2017 Q4 | 408 Thousand NZD | 0.0% |
| 2017 FY | 8.06 Million NZD | 62.03% |
| 2017 Q2 | 1.74 Million NZD | 0.0% |
| 2017 Q1 | 1.74 Million NZD | -12.72% |
| 2016 FY | 4.97 Million NZD | 161.87% |
| 2016 Q4 | 2 Million NZD | 0.0% |
| 2016 Q1 | 1.18 Million NZD | 15.56% |
| 2016 Q2 | 1.18 Million NZD | 0.0% |
| 2016 Q3 | 2 Million NZD | 68.92% |
| 2015 Q4 | 1.02 Million NZD | 0.0% |
| 2015 FY | 1.9 Million NZD | 263.29% |
| 2015 Q3 | 1.02 Million NZD | 58.75% |
| 2015 Q2 | 646.5 Thousand NZD | 0.0% |
| 2015 Q1 | 646.5 Thousand NZD | 210.53% |
| 2014 Q2 | 53.5 Thousand NZD | 0.0% |
| 2014 Q1 | 53.5 Thousand NZD | 141.27% |
| 2014 FY | 523 Thousand NZD | 187.36% |
| 2014 Q4 | 208.19 Thousand NZD | 0.0% |
| 2014 Q3 | 208.19 Thousand NZD | 289.14% |
| 2013 Q3 | 22.17 Thousand NZD | 0.0% |
| 2013 Q4 | 22.17 Thousand NZD | 0.0% |
| 2013 FY | 182 Thousand NZD | -8.08% |
| 2012 FY | 198 Thousand NZD | 39500.0% |
| 2011 FY | 500.00 NZD | 0.0% |
| 2010 FY | - NZD | -100.0% |
| 2009 FY | 220 Thousand NZD | 168.29% |
| 2008 FY | 82 Thousand NZD | 0.0% |
| 2007 FY | - NZD | 0.0% |
| 2006 FY | - NZD | -100.0% |
| 2005 FY | 50 Thousand NZD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Australian Clinical Labs Limited | 689.72 Million AUD | 96.221% |
| BCAL Diagnostics Limited | 3.09 Million AUD | -741.237% |
| Genetic Signatures Limited | 9.76 Million AUD | -166.868% |
| Genetic Technologies Limited | 7.66 Million AUD | -240.027% |
| Healius Limited | 1.74 Billion AUD | 98.507% |
| Imagion Biosystems Limited | 1.36 Million AUD | -1805.872% |
| Integral Diagnostics Limited | 469.69 Million AUD | 94.451% |
| INOVIQ Ltd | 535.11 Thousand AUD | -4770.394% |
| Microba Life Sciences Limited | 12.09 Million AUD | -115.569% |
| Monash IVF Group Limited | 254.96 Million AUD | 89.778% |
| Rhythm Biosciences Limited | 1.69 Million AUD | -1442.02% |
| Sonic Healthcare Limited | 8.93 Billion AUD | 99.708% |